Clinical Trial Update: Atrial Fibrillation Rate Control Therapy Guided By Continuous Ambulatory Monitoring [NA]

View source ↗

Summary

The clinical trial evaluating rate-control therapy for atrial fibrillation guided by continuous ambulatory monitoring has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN